Gibney, G. T.; Zager, J. S. (2013). “Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies”. Expert Opinion on Drug Metabolism & Toxicology9 (7): 1. doi:10.1517/17425255.2013.794220. PMID23621583.
Gibney, G. T.; Zager, J. S. (2013). “Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies”. Expert Opinion on Drug Metabolism & Toxicology9 (7): 1. doi:10.1517/17425255.2013.794220. PMID23621583.